Skip to main content

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

EPRX holding history

Eupraxia Pharmaceuticals Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EPRX overviewAll 13F holders of EPRXFull Q2 2026 holdings

Shares (Q2 2026)
611,400
Value
$4.04M
% of portfolio
0.3%
Quarters held
2
Since Q1 2026
Holdings of EPRX by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026611,400$4.04M0.3%−88,600−12.7%ReducedHolders
Q1 2026700,000$5.07M0.3%+700,000NewHolders